Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

LETI Pharma S.L.U.

Spain Calle Del Sol 5, Zona Industrial Tres Cantos, 28760 Tres Cantos, Spain

About the sponsor

LETI Pharma S.L.U. focuses on subcutaneous immunotherapy for allergic rhinoconjunctivitis, with research centered on clinical responses to house dust mite and pollen allergens.

  • Dermatophagoides pteronyssinus and Dermatophagoides farinae
  • Grass pollen immunotherapy
  • Olive pollen immunotherapy

The sponsor’s trials examine treatment effects in patients with persistent nasal and ocular allergy symptoms, including those with controlled asthma.

About Specializations

LETI Pharma S.L.U. runs clinical trials in conditions such as Conjunctivitis allergic, Conjunctivitis, Mite allergy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Conjunctivitis allergic+1

Recruiting

Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lolium perenne pollen, depigmented polymerized extract
  • Sponsor:LETI Pharma S.L.U.

Conjunctivitis allergic+1

Recruiting

Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lolium perenne pollen, depigmented polymerized extract
  • Sponsor:LETI Pharma S.L.U.

Mite allergy

Recruiting

A study testing dust mite allergy extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae for patients with allergic rhinoconjunctivitis with or without controlled asthma

Registered drug
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:LETI Pharma S.L.U.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.